My primary focus of interest is the preclinical evaluation of PET imaging ligands. Establishing a pharmacokinetic pig model for the characterization of novel radiotracers to measure pathological alpha-synuclein will be my intent. My curiosity also lies in psychedelic research and the molecular pathways associated with its pharmacological effects.